15 minutes delayed
DECIPHERA PHARMACEUTICALS INC COM reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of DECIPHERA PHARMACEUTICALS INC COM using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
DCPH | Deciphera Pharmaceuticals | -$0.57 | — | — | — | $38.30M | — | — | — | 08/07/2024 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$0.60 | -$0.55 | -$0.52 | 5.45% | $33.45M | $46.28M | $45.00M | -2.77% | 05/10/2024 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$0.60 | -$0.58 | -$0.54 | 6.90% | $36.34M | $45.92M | $48.30M | 5.17% | 02/06/2024 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$0.55 | -$0.61 | -$0.58 | 4.92% | $35.97M | $39.35M | $43.31M | 10.07% | 10/30/2023 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$0.60 | -$0.62 | -$0.57 | 8.06% | $32.49M | $35.88M | $38.30M | 6.76% | 08/09/2023 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$0.80 | -$0.59 | -$0.60 | -1.69% | $29.22M | $35.80M | $33.45M | -6.58% | 05/03/2023 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$1.51 | -$0.56 | -$0.60 | -7.14% | $24.20M | $35.75M | $36.34M | 1.66% | 02/07/2023 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$1.37 | -$0.58 | -$0.55 | 5.17% | $23.22M | $33.15M | $35.97M | 8.52% | 11/03/2022 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$1.21 | -$0.66 | -$0.60 | 9.09% | $23.57M | — | $32.49M | — | 08/04/2022 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$1.06 | — | -$0.80 | — | $25.16M | $26.43M | $29.22M | 10.57% | 05/04/2022 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$1.10 | — | -$1.51 | — | $19.49M | — | $24.20M | — | 02/08/2022 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$1.13 | -$1.28 | -$1.37 | -7.03% | $15.45M | $23.36M | $23.22M | -0.60% | 11/02/2021 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$1.20 | -$1.15 | -$1.21 | -5.22% | $7.09M | $22.00M | $23.57M | 7.15% | 08/03/2021 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$1.36 | -$1.07 | -$1.06 | 0.93% | $62.00K | $22.41M | $25.16M | 12.25% | 05/04/2021 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$1.31 | -$1.15 | -$1.10 | 4.35% | $0.00 | $18.93M | $19.49M | 2.94% | 02/09/2021 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$1.28 | -$1.30 | -$1.13 | 13.08% | — | $7.05M | $15.45M | 119.13% | 11/05/2020 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$0.56 | -$1.37 | -$1.20 | 12.41% | $25.00M | $900.00K | $7.09M | 687.78% | 08/04/2020 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$1.25 | -$1.25 | -$1.36 | -8.80% | $0.00 | $210.00K | $62.00K | -70.48% | 05/05/2020 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$0.86 | -$1.18 | -$1.31 | -11.02% | $0.00 | $1.15M | $0.00 | -100.00% | 03/09/2020 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$0.65 | -$1.16 | -$1.28 | -10.34% | $0.00 | $132.10M | $0.00 | -100.00% | 11/04/2019 | Get Alert |
DCPH | Deciphera Pharmaceuticals | -$0.65 | -$1.11 | -$0.56 | 49.55% | $0.00 | — | $25.00M | — | 08/02/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-10 | $-0.52 | $-0.55 | 5.45 % |
Dec 2023 | 2024-02-06 | $-0.54 | $-0.58 | 6.90 % |
Sep 2023 | 2023-10-30 | $-0.58 | $-0.61 | 4.92 % |
Jun 2023 | 2023-08-09 | $-0.57 | $-0.62 | 8.06 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-10 | $45.00M | $46.28M | -2.77 % |
Dec 2023 | 2024-02-06 | $48.30M | $45.92M | 5.17 % |
Sep 2023 | 2023-10-30 | $43.31M | $39.35M | 10.1 % |
Jun 2023 | 2023-08-09 | $38.30M | $35.88M | 6.76 % |
DECIPHERA PHARMACEUTICALS INC COM (DCPH) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on May 10, 2024 for Q1.
The Actual EPS was $-0.52, which beat the estimate of $-0.55.
The Actual Revenue was $45M, which missed the estimate of $46.3M.
Browse earnings estimates, EPS, and revenue on all stocks.